SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,942.40 -786.87
( -1.05%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,031.31 -292.98
(-0.45%)

Nikkei 225

10,879.96 39.61
(0.37%)

Forex

USD-INR

94.85 -0.23
(-0.24%)

EUR-INR

106.35 0.11
(0.11%)

GBP-INR

125.73 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Pharmaids Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524572

INE117D01018

15.1357311

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

106.4

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	10.60	2.34	0.03	0.00	3.94	8.55
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	10.60	2.34	0.03	0.00	3.94	8.55
Other Income	3.81	1.02	0.80	0.00	0.02	0.03
Stock Adjustments	-0.12	-0.11	0.23	-0.89	0.52	0.37
Total Income	14.29	3.25	1.06	-0.89	4.48	8.95
EXPENDITURE :
Raw Materials	11.31	1.90	0.25	0.00	4.09	8.53
Power & Fuel Cost	0.27	0.05	0.01	0.00	0.00	0.00
Employee Cost	5.40	3.42	1.99	1.13	0.04	0.04
Other Manufacturing Expenses	0.15	0.02	0.04	0.02	0.00	0.00
Selling & Administrative Expenses	6.96	1.69	1.45	0.80	0.19	0.23
Miscellaneous Expenses	0.65	2.41	2.88	7.06	0.00	0.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	24.74	9.49	6.62	9.00	4.32	8.82
Operating Profit	-10.43	-6.24	-5.58	-9.89	0.15	0.13
Interest	3.31	2.15	0.33	0.00	0.00	0.00
Gross Profit	-13.74	-8.39	-5.91	-9.89	0.15	0.13
Depreciation	0.21	0.20	0.18	0.02	0.01	0.04
Profit Before Tax	-13.95	-8.59	-6.09	-9.91	0.14	0.09
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-3.52	-1.31	-1.14	-2.35	0.00	0.00
Reported Net Profit	-10.44	-7.28	-4.95	-7.56	0.15	0.09
Extraordinary Items	3.11	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	-13.55	-7.28	-4.95	-7.56	0.15	0.09
Adjustment below Net Profit	0.00	0.00	-0.04	0.00	0.00	0.00
P & L Balance brought forward	-22.16	-14.88	-9.89	-2.33	-2.48	-2.57
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-32.60	-22.16	-14.88	-9.89	-2.33	-2.48
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-2.96	-2.06	-1.40	-3.52	0.14	0.09
Earnings Per Share(Adj)-Unit Curr	-2.96	-2.06	-1.40	-3.52	0.14	0.09
Book Value-Unit Curr	15.14	18.09	20.15	10.46	8.44	8.30
Book Value(Adj)-Unit Curr	15.14	18.09	20.15	10.46	8.44	8.30

73,942.40 -786.87 ( -1.05%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,031.31 -292.98 (-0.45%)

10,879.96 39.61 (0.37%)

94.85 -0.23 (-0.24%)

106.35 0.11 (0.11%)

125.73 -0.01 (-0.01%)

0.60 0.00 (0.07%)